| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CLOVIS ONCOLOGY INC | 3,531,487 | 127,310,000 | 12.25% | ||
| 2 | ARIAD PHARMACEUTICALS INC | 8,695,742 | 119,045,000 | 11.46% | ||
| 3 | MALLINCKRODT PUB LTD CO SHS | 1,560,157 | 108,837,000 | 10.48% | ||
| 4 | UNITED THERAPEUTICS | 818,700 | 96,672,000 | 9.30% | ||
| 5 | AMARIN CORP PLC | 24,652,380 | 78,641,000 | 7.57% | ||
| 6 | RETROPHIN INC COM | 3,084,947 | 69,041,000 | 6.65% | ||
| 7 | HORIZON PHARMA PLC | 3,698,903 | 67,061,000 | 6.45% | ||
| 8 | AKORN INC | 2,200,000 | 59,972,000 | 5.77% | ||
| 9 | IRONWOOD PHARMACEUTICALS INC COM CL A | 3,296,539 | 52,349,000 | 5.04% | ||
| 10 | MEDNAX INC | 660,000 | 43,725,000 | 4.21% | ||
| 11 | ANI PHARMACEUTICALS INC COM | 653,258 | 43,344,000 | 4.17% | ||
| 12 | GLOBUS MED INC | 1,860,000 | 41,980,000 | 4.04% | ||
| 13 | SANOFI SPOND FUNSPONSORED ADR | 5,950,225 | 37,784,000 | 3.64% | ||
| 14 | ORTHOFIX INTERNATIONAL NV | 634,496 | 27,137,000 | 2.61% | ||
| 15 | MYRIAD GENETICS INC | 850,000 | 17,485,000 | 1.68% | ||
| 16 | EHEALTH INC COM | 1,154,711 | 12,944,000 | 1.25% | ||
| 17 | HEALTHSTREAM INC COM | 340,847 | 9,407,000 | 0.91% | ||
| 18 | ADMA BIOLOGICS, INC. | 1,273,933 | 9,223,000 | 0.89% | ||
| 19 | VERICEL CORP | 2,232,940 | 6,252,000 | 0.60% | ||
| 20 | ATRICURE INC | 231,926 | 3,667,000 | 0.35% | ||
| 21 | BIOLASE INC | 1,790,992 | 3,134,000 | 0.30% | ||
| 22 | SEASPINE HLDGS CORP COM | 262,934 | 2,658,000 | 0.26% | ||
| 23 | VERACYTE INC | 165,825 | 1,262,000 | 0.12% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-16-004746, filed 2016.11.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
